{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:14:48Z","timestamp":1758608088714,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rxeng.2025.101668","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:35:35Z","timestamp":1754408135000},"page":"101668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical applications of bladder magnetic resonance imaging: Beyond the VI-RADS\u00ae classification"],"prefix":"10.1016","volume":"67","author":[{"given":"J.","family":"Etxano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez-Maseda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rxeng.2025.101668_bib0005","unstructured":"International Agency for Research on Cancer, Cancer factsheets. Bladder, 2020, IARC; Lyon Cedex, [Accessed 13 Oct 2024]. Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/30-Bladder fact-sheet.pdf."},{"key":"10.1016\/j.rxeng.2025.101668_bib0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rxeng.2025.101668_bib0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3","article-title":"The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"78","author":"Fleshner","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.rxeng.2025.101668_bib0020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2214\/AJR.16.17114","article-title":"Role of imaging in the local staging of urothelial carcinoma of the bladder","volume":"208","author":"Lee","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2014.02.031","article-title":"So much cost, such little progress","volume":"66","author":"Bryan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric Magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report","volume":"47","author":"Pecoraro","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.rxeng.2025.101668_bib0040","series-title":"EAU guidelines on muscle invasive and metastatic bladder cancer","first-page":"15","author":"Witjes (Chair)","year":"2024"},{"key":"10.1016\/j.rxeng.2025.101668_bib0045","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1148\/rg.266065126","article-title":"From the archives of the AFIP: inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation","volume":"26","author":"Wong-You-Cheong","year":"2006","journal-title":"Radiographics"},{"key":"10.1016\/j.rxeng.2025.101668_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiology.187.1.8451403","article-title":"Bladder wall morphology: in vitro MR imaging-histopathologic correlation","volume":"187","author":"Narumi","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.rxeng.2025.101668_bib0055","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2214\/AJR.08.1962","article-title":"Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma","volume":"192","author":"Ma","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0302-2838(01)00035-5","article-title":"Prediction of muscle invasion of bladder cancer by cystoscopy","volume":"41","author":"Satoh","year":"2002","journal-title":"Eur Urol."},{"key":"10.1016\/j.rxeng.2025.101668_bib0065","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2214\/AJR.20.22763","article-title":"Overview of VI-RADS in bladder cancer","volume":"214","author":"Pecoraro","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jmri.29103","article-title":"Development and validation of an MRI-based nomogram for preoperative detection of muscle invasion in VI-RADS 3","volume":"60","author":"Yu","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.rxeng.2025.101668_bib0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jmri.29184","article-title":"Role of additional MRI-based morphologic measurements on the performance of VI-RADS for muscle-invasive bladder cancer","volume":"60","author":"Gong","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.rxeng.2025.101668_bib0080","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220034","article-title":"Urinary bladder masses, rare subtypes, and masslike lesions: radiologic-pathologic correlation","volume":"43","author":"Hoegger","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.rxeng.2025.101668_bib0085","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.21037\/tcr-20-2169","article-title":"Variant histology in bladder cancer: diagnostic and clinical implications","volume":"9","author":"Black","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.rxeng.2025.101668_bib0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0095","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1016\/j.clgc.2019.04.014","article-title":"Quality control indicators for transurethral resection of non-muscle-invasive bladder cancer","volume":"17","author":"Akand","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.rxeng.2025.101668_bib0100","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11255-023-03867-9","article-title":"Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?","volume":"56","author":"Beijert","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00345-006-0061-7","article-title":"Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure","volume":"24","author":"Stein","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0120","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0125","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0130","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","article-title":"Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer","volume":"61","author":"Rosenblatt","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0135","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/PAS.0000000000001371","article-title":"Multicenter validation of histopathologic tumor regression grade after neoadjuvant chemotherapy in muscle-invasive bladder carcinoma","volume":"43","author":"Voskuilen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(05)64047-5","article-title":"An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma","volume":"169","author":"S\u00e1nchez-Ortiz","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","article-title":"Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes","volume":"2","author":"Boeri","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40644-024-00696-6","article-title":"MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy","volume":"24","author":"Zhang","year":"2024","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.rxeng.2025.101668_bib0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.juro.2018.04.065","article-title":"Can renal and bladder ultrasound replace computerized tomography urogram in patients investigates for microscopic hematuria?","volume":"200","author":"Tan","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0160","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0022-5347(05)67522-2","article-title":"Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy","volume":"163","author":"Paik","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.193.1.8090898","article-title":"Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging","volume":"193","author":"Kim","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.rxeng.2025.101668_bib0170","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1148\/radiol.2017171028","article-title":"The diagnostic value of MR imaging in differentiating T staging of bladder cancer: a meta-analysis","volume":"286","author":"Huang","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.rxeng.2025.101668_bib0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bju.14366","article-title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis","volume":"122","author":"Gandhi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.rxeng.2025.101668_bib0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejrad.2017.07.021","article-title":"Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: a systematic review and meta-analysis","volume":"95","author":"Woo","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0185","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00261-018-1458-7","article-title":"Diagnostic performance of diffusion-weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: utility of evaluating the morphology of the reactive tumor stalk","volume":"43","author":"Razik","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0190","first-page":"866","article-title":"Value of MRI in local staging of bladder cancer","volume":"10","author":"Ghafoori","year":"2013","journal-title":"Urol J"},{"key":"10.1016\/j.rxeng.2025.101668_bib0195","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.acra.2013.02.012","article-title":"Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI","volume":"20","author":"Wu","year":"2013","journal-title":"Acad Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2024.09.013","article-title":"The role of multiparametric magnetic resonance imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the management of patients with bladder cancer: Vision of the American College of Radiology VI-RADS Steering Committee","volume":"86","author":"Panebianco","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","article-title":"Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"3","author":"Woo","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eururo.2019.03.012","article-title":"Diagnostic accuracy and interobserver agreement for the vesical imaging-reporting and data system for muscle-invasive bladder cancer: a multireader validation study","volume":"76","author":"Ueno","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2019182506","article-title":"Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.rxeng.2025.101668_bib0220","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bju.15188","volume":"126","author":"Del Giudice","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.rxeng.2025.101668_bib0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/bco2.365","article-title":"Comparison of staging MRI to re-resection for localised bladder cancer: narrative review","volume":"5","author":"Klempfner","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.rxeng.2025.101668_bib0230","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","article-title":"A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study","volume":"127","author":"Bicchetti","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.rxeng.2025.101668_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2021.02.021","article-title":"Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study","volume":"80","author":"Bryan","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0240","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.clgc.2022.03.002","article-title":"Proposal for a new vesical imaging-reporting and data system (VI-RADS)-based algorithm for the management of bladder cancer: a paradigm shift from the current transurethral resection of bladder tumor (TURBT)-dependent practice","volume":"20","author":"Taguchi","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.rxeng.2025.101668_bib0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","article-title":"Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection","volume":"77","author":"Del Giudice","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/DEHT5407","article-title":"Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT","volume":"28","author":"James","year":"2024","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.rxeng.2025.101668_bib0255","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1007\/s00330-022-08766-8","article-title":"The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program","volume":"32","author":"da Silva","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0260","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00261-024-04245-4","article-title":"Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis","volume":"49","author":"Chai","year":"2024","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rxeng.2025.101668_bib0270","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/annonc\/mdu126","volume":"25","author":"Kitamura","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0275","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1007\/s00330-023-09627-8","article-title":"Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer","volume":"33","author":"Kimura","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0280","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2017.10.002","article-title":"A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"36","author":"Fahmy","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jmri.27361","article-title":"VI-RADS for bladder cancer: current applications and future developments","volume":"55","author":"Panebianco","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.rxeng.2025.101668_bib0295","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.euo.2020.06.004","article-title":"The value of multiparametric magnetic resonance imaging sequences to assist in the decision making of muscle-invasive bladder cancer","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.rxeng.2025.101668_bib0300","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bju.16191","article-title":"Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer","volume":"133","author":"Necchi","year":"2024","journal-title":"BJU Int"}],"container-title":["Radiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173510725001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173510725001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:07:20Z","timestamp":1758604040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173510725001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2173510725001132"],"URL":"https:\/\/doi.org\/10.1016\/j.rxeng.2025.101668","relation":{},"ISSN":["2173-5107"],"issn-type":[{"type":"print","value":"2173-5107"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical applications of bladder magnetic resonance imaging: Beyond the VI-RADS\u00ae classification","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rxeng.2025.101668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2025.01.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SERAM. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101668"}}